Suppr超能文献

用于癌症诊疗的花菁缀合物。

Cyanine conjugates in cancer theranostics.

作者信息

Li Yang, Zhou Yiming, Yue Xiuli, Dai Zhifei

机构信息

Department of Biomedical Engineering, College of Engineering, Peking University, Beijing 100871, China.

School of Environment, Harbin Institute of Technology, Harbin 150001, China.

出版信息

Bioact Mater. 2020 Sep 29;6(3):794-809. doi: 10.1016/j.bioactmat.2020.09.009. eCollection 2021 Mar.

Abstract

Cyanine is a meritorious fluorogenic core for the construction of fluorescent probes and its phototherapeutic potential has been enthusiastically explored as well. Alternatively, the covalent conjugation of cyanine with other potent therapeutic agents not only boosts its therapeutic efficacy but also broadens its therapeutic modality. Herein, we summarize miscellaneous cyanine-therapeutic agent conjugates in cancer theranostics from literature published between 2014 and 2020. The application scenarios of such theranostic cyanine conjugates covered common cancer therapeutic modalities, including chemotherapy, phototherapy and targeted therapy. Besides, cyanine conjugates that serve as nanocarriers for drug delivery are introduced as well. In an additional section, we analyze the potential of these conjugates for clinical translation. Overall, this review is aimed to stimulate research interest in exploring unattempted therapeutic agents and novel conjugation strategies and hopefully, accelerate clinical translation in this field.

摘要

花菁是构建荧光探针的一种优异的荧光核心,其光治疗潜力也得到了积极探索。此外,花菁与其他强效治疗剂的共价结合不仅提高了其治疗效果,还拓宽了其治疗方式。在此,我们从2014年至2020年发表的文献中总结了用于癌症诊疗的各种花菁-治疗剂共轭物。此类诊疗用花菁共轭物的应用场景涵盖了常见的癌症治疗方式,包括化疗、光疗和靶向治疗。此外,还介绍了用作药物递送纳米载体的花菁共轭物。在另一部分中,我们分析了这些共轭物临床转化的潜力。总体而言,本综述旨在激发探索未尝试的治疗剂和新型共轭策略的研究兴趣,并有望加速该领域的临床转化。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1e1b/7528000/a8bb282e9b68/fx1.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验